LGND Prices $625M Notes
Ligand Pharmaceuticals prices upsized $625M 0.0% convertible senior notes offering due 2031 and plans to repurchase shares
This is a real-time flash headline. A verified provider body is not available, so SquawkNews does not present it as a full article.